A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia
- 1 October 1998
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 103 (1), 100-109
- https://doi.org/10.1046/j.1365-2141.1998.00948.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Treatment of acute myeloblastic leukemia in adults. The GOELAM experienceHematology and Cell Therapy, 1996
- A randomized placebo-controlled phase III study of granulocyte- macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)Blood, 1995
- Systematic Reviews: Obtaining data from randomised controlled trials: how much do we need for reliable and informative meta-analyses?BMJ, 1994
- Intensive Postremission Chemotherapy in Adults with Acute Myeloid LeukemiaNew England Journal of Medicine, 1994
- Meta-analysis of the literature or of individual patient data: is there a difference?The Lancet, 1993
- A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study.Journal of Clinical Oncology, 1992
- A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemiaEuropean Journal of Cancer and Clinical Oncology, 1991
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- Why do we need systematic overviews of randomized trials? (Transcript of an oral presentation, modified by the editors)Statistics in Medicine, 1987